共 334 条
[1]
Siegel RL(2015)Cancer statistics, 2015 CA Cancer J Clin 65 5-29
[2]
Miller KD(2010)Survival and quality of life of cholangiocarcinoma patients: a prospective study over a 4 year period J Gastrointestin Liver Dis 19 285-290
[3]
Jemal A(2003)A 10-year experience in the management of gallbladder cancer Hpb 5 159-166
[4]
Mihalache F(2000)Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery Scand J Gastroenterol 35 1221-1228
[5]
Tantau M(2011)The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma Dig Dis Sci 56 2491-2496
[6]
Diaconu B(2011)The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Journal of gastrointestinal oncology 3 105-119
[7]
Acalovschi M(2006)Diagnosis of pancreatic cancer HPB 8 337-342
[8]
Smith G(2010)Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer Gastroenterology 138 949-957
[9]
Parks R(2010)Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles Metabolomics 6 78-95
[10]
Madhavan K(2013)MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls Clin Cancer Res 19 3600-3610